Conditional Vascular Cell Adhesion Molecule 1 Deletion in Mice

Pandelakis A. Koni(Augusta University), Sunil K. Joshi(Augusta University), Ulla-Angela Temann(Yale University), Dian L. Olson(Biogen (United States)), Linda C. Burkly(Biogen (United States)), Richard A. Flavell(Howard Hughes Medical Institute)
The Journal of Experimental Medicine
March 19, 2001
Cited by 495Open Access
Full Text

Abstract

We generated vascular cell adhesion molecule (VCAM)-1 "knock-in" mice and Cre recombinase transgenic mice to delete the VCAM-1 gene (vcam-1) in whole mice, thereby overcoming the embryonic lethality seen with conventional vcam-1-deficient mice. vcam-1 knock-in mice expressed normal levels of VCAM-1 but showed loss of VCAM-1 on endothelial and hematopoietic cells when interbred with a "TIE2Cre" transgene. Analysis of peripheral blood from conditional vcam-1-deficient mice revealed mild leukocytosis, including elevated immature B cell numbers. Conversely, the bone marrow (BM) had reduced immature B cell numbers, but normal numbers of pro-B cells. vcam-1-deficient mice also had reduced mature IgD+ B and T cells in BM and a greatly reduced capacity to support short-term migration of transferred B cells, CD4+ T cells, CD8+ T cells, and preactivated CD4+ T cells to the BM. Thus, we report an until now unappreciated dominant role for VCAM-1 in lymphocyte homing to BM.


Related Papers

No related papers found

Powered by citation graph analysis